Breast cancer aromatase expression evaluated by the novel antibody 677: Correlations to intra-tumor estrogen levels and hormone receptor status-Reference-Cited by-同舟云学术

Breast cancer aromatase expression evaluated by the novel antibody 677: Correlations to intra-tumor estrogen levels and hormone receptor status

Published:2010-02 Issue:4-5 Volume:118 Page:237-241
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Geisler Jürgen,Suzuki Takashi,Helle Hildegunn,Miki Yasuhiro,Nagasaki Shuji,Duong Nhat K.,Ekse Dagfinn,Aas Turid,Evans Dean B.,Lønning Per E.,Sasano Hironobu

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference26 articles.

1. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies;Key;J. Natl. Cancer Inst.,2002

2. Aromatase inhibitors as adjuvant treatment of breast cancer;Geisler;Crit. Rev. Oncol. Hematol.,2006

3. Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer;Lonning;J. Steroid Biochem.,1990

4. On the significance of in situ production of oestrogens in human breast cancer tissue;Blankenstein;J. Steroid Biochem. Mol. Biol.,1992

5. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue;van Landeghem;Cancer Res.,1985

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DREAM On, DREAM Off: A Review of the Estrogen Paradox in Luminal A Breast Cancers;Biomedicines;2024-06-12

2. Superior suppression of serum estrogens during neoadjuvant breast cancer treatment with letrozole compared to exemestane;Breast Cancer Research and Treatment;2024-04-23

3. Bone Safety Profile of Steroidal Aromatase Inhibitor in Comparison to Nonsteroidal Aromatase Inhibitors in Postmenopausal Women with Breast Cancer: A Network Meta-Analysis;Breast Care;2022

4. The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study;Frontiers in Oncology;2021-05-20

5. Investigation of Combination Treatment With an Aromatase Inhibitor Exemestane and Carboplatin-Based Therapy for Postmenopausal Women With Advanced NSCLC;JTO Clinical and Research Reports;2021-04